Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov 16;4(1-4):18-23.
doi: 10.1159/000481727. eCollection 2017 Jan-Dec.

A 71-Year-Old Female with Myocardial Infarction and Long-Standing Ulcers on the Thigh

Affiliations
Case Reports

A 71-Year-Old Female with Myocardial Infarction and Long-Standing Ulcers on the Thigh

Eduardo De Flammineis et al. Dermatopathology (Basel). .

Abstract

Calciphylaxis is most commonly encountered in patients with end-stage renal disease; however, it is increasingly observed in nonuremic patients as well. It is important to consider and diagnose nonuremic calciphylaxis early, as prompt treatment and mitigation of associated risk factors is essential to improve long-term outcomes for these patients. Here, we present the case of a 71-year-old woman with atrial fibrillation on warfarin, but without renal disease, who presented with two long-standing ulcers on her thigh and was diagnosed with the aid of biopsy with calciphylaxis. We review the existing literature on the subject and offer this case as a representative report of a clinicopathologic correlation for this disorder.

Keywords: Calciphylaxis; Nonuremic calciphylaxis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Ulcers of the left anterior (a) and left medial (b) thigh with surrounding stellate erythema.
Fig. 2.
Fig. 2.
Calcium deposition in walls of subcutaneous vessels. a H&E. ×40. b H&E. ×100. c Von Kossa stain. ×400.

References

    1. Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66:133–146. - PMC - PubMed
    1. Weenig RH, Sewell LD, Davis MDP, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56:569–579. - PubMed
    1. Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS. The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial. Clin J Am Soc Nephrol. 2015;10:800–807. - PMC - PubMed
    1. Wong JJ, Laumann A, Martinez M. Calciphylaxis and antiphospholipid antibody syndrome. J Am Acad Dermatol. 2000;42((pt 1)):849. - PubMed
    1. Lee JL, Naguwa SM, Cheema G, Gershwin ME. Recognizing calcific uremic arteriolopathy in autoimmune disease: an emerging mimicker of vasculitis. Autoimmun Rev. 2008;7:638–643. - PubMed

Publication types